Provides experiential support & guidance for Translational Research (From Bench to Bedside) in the development of therapeutics and diagnostics for the biotech industry.
DEVELOPMENT PROGRAM STRATEGY
Starting with the correct development strategy is key. Completion of the appropriate background research to assess whether the scientific rationale meets the unmet medical need is fundamental for success including, but not limited to, the following:
Development of foundational building-block Target Product/Diagnostic Profiles for ~10 year time-horizons
Understanding the importance of constructive interactions with Regulatory Authorities to enable collaboration on development strategy
Maintaining rigorous scientific review of generated data with informed know-how on next steps
Rowestil Consulting can be contacted at the following email address: